重新利用熟悉的:对慢性病的未来治疗选择
Rohan Bhadange1, Anil Bhanudas Gaikwad1
1Department of Pharmacy, Birla Institute of Technology and Science, Pilani, Pilani Campus, 333031, Rajasthan, India.
The Journal of pharmacy and pharmacology
|January 20, 2025
概括
药物再利用为治疗慢性病 (CKD) 提供了一个有希望的途径. 该战略探索现有的药物,以寻找新的应用,潜在地改善患者的治疗结果,并减缓疾病的进展.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 慢性病 (CKD) 是一个重大的全球健康挑战,疾病和死亡率不断增加.
- 目前用于CKD的治疗方法的有效性往往有限,并与不良副作用相关,这凸显了对新型治疗策略的需求.
- 药物重新定位,确定现有批准药物的新用途,成为加速开发有效CKD疗法的可行方法.
研究的目的:
- 审查药物重用在治疗慢性病 (CKD) 的潜力.
- 探索各种药物类别及其用于CKD治疗的药理学机制.
- 评估支持重定向药物减缓CKD进展和改善患者结果的临床证据.
主要方法:
- 对药理学机制和临床证据的文献综述,用于CKD中重新使用药物的临床证据.
- 识别和讨论各种药物类别,包括内扩剂,ET-1A受体对抗剂,双酸盐,MR对抗剂,DNA脱甲基化剂,NRF2激活剂,P2X7抑制剂,自调节剂和HIF-PHI.
- 批判性地检查这些重用剂对影响CKD进展的潜力.
主要成果:
- 几种药物类别,包括矿物质皮质体受体抗剂和NRF2激活剂,在治疗CKD方面表现有前途.
- 重用药物提供了潜在的机制来对抗CKD的病理生理学.
- 临床证据表明,某些重新定位的药物可以对管理CKD作出重大贡献.
结论:
- 药物重定向是一种有价值的策略,用于开发创新和有效的CKD治疗方法.
- 多学科的方法是必不可少的,以推进药物重定向努力在科.
- 重用已知药物具有显著的潜力,可以减缓CKD的进展并改善患者的健康结果.
相关概念视频
01:27Dialysis
257
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
257
01:10Nephrons
2.1K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
2.1K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
378
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
378
01:29Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70
01:45Kidney Structure
68.7K
The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
68.7K
01:11Renal Failure: Dose Adjustments
61
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
61